Presentation TCT 2025 TCT 486: Lipoprotein(a) as a Predictor of Lesion Complexity in Patients undergoing Elective Percutaneous Coronary Intervention : Insights from an Asian single center cohort Presenter: Melly Susanti October 27, 2025
Presentation TCT 2025 TCT 485: Lipoprotein(a) and Long-Term Cardiovascular Events in Patients With Coronary Vasospasm Presenter: Melly Susanti October 27, 2025
Presentation TCT 2025 TCT 480: Imparied high-density lipoprotein functionality assessed by cholesterol uptake capacity might cause plaque vulnerability and unfavorable prognosis after percutaneous coronary intervention. Presenter: Kotaro Higuchi October 27, 2025
Presentation TCT 2025 TCT 476: Synergistic Impact of Insulin Resistance and Hepatic Fibrosis on Cardiovascular Events in Patients with Coronary Artery Disease: A Machine Learning Subtyping and Interaction Analysis Presenter: Zhihao Zheng October 27, 2025
Presentation TCT 2025 TCT 515: Real-World Usage of a Prevail Paclitaxel-Coated Balloon Compared With Other Contemporary Drug-Coated Balloons for Diabetes Mellitus Presenter: David Erlinge October 27, 2025
Presentation TCT 2025 TCT 481: Strike Early, Strike Strong—But Retest Early as Well: Two-Week LDL-C Assessment Accurately Identifies Non-Responders to Triple Oral Lipid-Lowering Therapy in ACS Patients Undergoing PCI Presenter: Kunal Mahajan October 27, 2025
Presentation TCT 2025 TCT 477: Bariatrc Arterial Embolization: A Mini-invasive Intervention for Obesity Treatment Presenter: Gustavo Arturo Samaja October 27, 2025
Presentation TCT 2025 TCT 479: Impact of Baseline Metformin Use on Renal and Mortality Outcomes in Diabetic Patients Undergoing Cardiac Catheterization for Acute Coronary Syndrome: A Single Center Retrospective Cohort Study Presenter: Ishaq Khoury October 27, 2025
Presentation TCT 2025 TCT 470: Comparative Outcomes of Serum LDL Levels <55 mg/dL Versus 55–100 mg/dL for Primary Prevention of Undiagnosed Coronary Artery Disease: A Retrospective Cohort Study Presenter: Mehmet Cilingiroglu October 27, 2025
Presentation TCT 2025 TCT 474: Edoxaban Monotherapy for Atrial Fibrillation and Stable Coronary Artery Disease in Diabetic Patients: The EPIC-CAD Trial Presenter: Seunghan Lee October 27, 2025
Presentation TCT 2025 TCT 472: Prognostic effect of insulin resistance in patients with moderate-to-severe coronary artery calcification: a prospective cohort study Presenter: Zixiang Ye October 27, 2025
Presentation TCT 2025 TCT 471: Pericoronary Fat Attenuation Index Combined with Lp(a) for Predicting Post-PCI Adverse Outcomes in Coronary Artery Disease Patients Presenter: Zixiang Ye October 27, 2025
Presentation TCT 2025 TCT 475: Impact of Elevated Lipoprotein(a) on LDL Cholesterol Target Attainment Following PCI for Acute Coronary Syndrome Despite Intensive Triple Oral Lipid-Lowering Therapy: A Retrospective Cohort Study Presenter: Kunal Mahajan October 27, 2025
Presentation TCT 2025 Multi-Organ Ethanol Denervation to Treat Type 2 Diabetes Mellitus and Hypertension: 6-Month Results of an Early Feasibility Study Presenter: Ajay J. Kirtane October 27, 2025
Presentation TCT 2025 TCT 776: Clinical Effectiveness of Sodium-Glucose Co-Transporter 2 Inhibitors on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database Presenter: Aymen Ahmed October 26, 2025
Presentation TCT 2025 TCT 775: Clinical Effectiveness of Glucagon-Like Peptide-1 Receptor Agonist on Cardiovascular and Limb Outcomes in Patients with Type 2 Diabetes and Peripheral Artery Disease: Findings from the TriNetX Database Presenter: Aymen Ahmed October 26, 2025
Presentation TCT 2025 TCT 208: Multi-Organ Arterial Denervation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities (NECTAR IV Trial) Presenter: Horst Sievert October 26, 2025
Presentation TCT 2025 TCT 681: Impact of Intravascular Imaging-Guided Drug-Eluting Stent Implantation on Cardiac Mortality in Patients with Diabetes and Coronary Artery Disease: A Multicenter Cohort Study Presenter: Xiaofei Gao October 26, 2025
Presentation TCT 2025 TCT 640: Diabetes, Glucose Dysregulation, and Inflammatory Biomarkers as Predictors of Mortality and Adverse Events Following Transcatheter Aortic Valve Implantation: A Systematic Review and Meta-analysis Presenter: Mahsa Rezasoltani October 26, 2025
Presentation TCT 2025 TCT 748: Effects of SGLT2 Inhibitors on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus Undergoing Transcatheter Mitral Valve Repair: A Propensity-Matched Analysis Presenter: Mahmoud Abdelnabi October 25, 2025